nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—CYP3A5—Disulfiram—alcohol dependence	0.17	0.353	CbGbCtD
Sirolimus—ABCB1—Naltrexone—alcohol dependence	0.119	0.247	CbGbCtD
Sirolimus—ABCB1—Citalopram—alcohol dependence	0.079	0.164	CbGbCtD
Sirolimus—CYP3A4—Disulfiram—alcohol dependence	0.0664	0.138	CbGbCtD
Sirolimus—CYP3A4—Citalopram—alcohol dependence	0.0473	0.0981	CbGbCtD
Sirolimus—EIF4E—forebrain—alcohol dependence	0.00571	0.0458	CbGeAlD
Sirolimus—EIF4E—cardiovascular system—alcohol dependence	0.00483	0.0387	CbGeAlD
Sirolimus—EIF4E—pancreas—alcohol dependence	0.00469	0.0376	CbGeAlD
Sirolimus—EIF4E—gonad—alcohol dependence	0.00438	0.0351	CbGeAlD
Sirolimus—EIF4E—digestive system—alcohol dependence	0.00401	0.0321	CbGeAlD
Sirolimus—EIF4E—blood—alcohol dependence	0.00382	0.0306	CbGeAlD
Sirolimus—EIF4E—endocrine gland—alcohol dependence	0.00331	0.0266	CbGeAlD
Sirolimus—EIF4E—testis—alcohol dependence	0.00316	0.0253	CbGeAlD
Sirolimus—EIF4E—nervous system—alcohol dependence	0.0031	0.0249	CbGeAlD
Sirolimus—EIF4E—liver—alcohol dependence	0.00299	0.0239	CbGeAlD
Sirolimus—EIF4E—central nervous system—alcohol dependence	0.00298	0.0239	CbGeAlD
Sirolimus—EIF4E—brain—alcohol dependence	0.00237	0.019	CbGeAlD
Sirolimus—FGF2—midbrain—alcohol dependence	0.0023	0.0184	CbGeAlD
Sirolimus—MTOR—brainstem—alcohol dependence	0.00229	0.0184	CbGeAlD
Sirolimus—MTOR—forebrain—alcohol dependence	0.00221	0.0177	CbGeAlD
Sirolimus—FKBP1A—forebrain—alcohol dependence	0.00199	0.0159	CbGeAlD
Sirolimus—FGF2—testis—alcohol dependence	0.00193	0.0154	CbGeAlD
Sirolimus—MTOR—cardiovascular system—alcohol dependence	0.00187	0.015	CbGeAlD
Sirolimus—FKBP1A—adrenal cortex—alcohol dependence	0.00184	0.0148	CbGeAlD
Sirolimus—MTOR—pancreas—alcohol dependence	0.00182	0.0146	CbGeAlD
Sirolimus—FGF2—cerebellum—alcohol dependence	0.00178	0.0143	CbGeAlD
Sirolimus—SLC47A1—brainstem—alcohol dependence	0.00177	0.0142	CbGeAlD
Sirolimus—MTOR—gonad—alcohol dependence	0.0017	0.0136	CbGeAlD
Sirolimus—FKBP1A—cardiovascular system—alcohol dependence	0.00168	0.0135	CbGeAlD
Sirolimus—FKBP1A—pancreas—alcohol dependence	0.00163	0.0131	CbGeAlD
Sirolimus—SLC47A1—adrenal cortex—alcohol dependence	0.00158	0.0127	CbGeAlD
Sirolimus—MTOR—digestive system—alcohol dependence	0.00155	0.0124	CbGeAlD
Sirolimus—FKBP1A—gonad—alcohol dependence	0.00152	0.0122	CbGeAlD
Sirolimus—MTOR—blood—alcohol dependence	0.00148	0.0118	CbGeAlD
Sirolimus—FGF2—brain—alcohol dependence	0.00144	0.0116	CbGeAlD
Sirolimus—CYP3A7—endocrine gland—alcohol dependence	0.00143	0.0114	CbGeAlD
Sirolimus—FKBP1A—digestive system—alcohol dependence	0.00139	0.0112	CbGeAlD
Sirolimus—FKBP1A—blood—alcohol dependence	0.00133	0.0107	CbGeAlD
Sirolimus—FKBP1A—midbrain—alcohol dependence	0.00131	0.0105	CbGeAlD
Sirolimus—SLC47A1—gonad—alcohol dependence	0.00131	0.0105	CbGeAlD
Sirolimus—CYP3A7—liver—alcohol dependence	0.00129	0.0103	CbGeAlD
Sirolimus—MTOR—endocrine gland—alcohol dependence	0.00128	0.0103	CbGeAlD
Sirolimus—MTOR—testis—alcohol dependence	0.00122	0.0098	CbGeAlD
Sirolimus—MTOR—nervous system—alcohol dependence	0.0012	0.00962	CbGeAlD
Sirolimus—SLC47A1—digestive system—alcohol dependence	0.0012	0.00961	CbGeAlD
Sirolimus—SLCO1B1—digestive system—alcohol dependence	0.00118	0.00949	CbGeAlD
Sirolimus—MTOR—liver—alcohol dependence	0.00116	0.00927	CbGeAlD
Sirolimus—MTOR—central nervous system—alcohol dependence	0.00115	0.00926	CbGeAlD
Sirolimus—FKBP1A—endocrine gland—alcohol dependence	0.00115	0.00924	CbGeAlD
Sirolimus—SLC47A1—blood—alcohol dependence	0.00114	0.00916	CbGeAlD
Sirolimus—MTOR—cerebellum—alcohol dependence	0.00113	0.00905	CbGeAlD
Sirolimus—SLCO1B1—blood—alcohol dependence	0.00113	0.00904	CbGeAlD
Sirolimus—FKBP1A—testis—alcohol dependence	0.0011	0.00882	CbGeAlD
Sirolimus—CYP3A7-CYP3A51P—liver—alcohol dependence	0.00109	0.00877	CbGeAlD
Sirolimus—FKBP1A—nervous system—alcohol dependence	0.00108	0.00865	CbGeAlD
Sirolimus—FKBP1A—liver—alcohol dependence	0.00104	0.00833	CbGeAlD
Sirolimus—FKBP1A—central nervous system—alcohol dependence	0.00104	0.00833	CbGeAlD
Sirolimus—FKBP1A—cerebellum—alcohol dependence	0.00102	0.00814	CbGeAlD
Sirolimus—SLC47A1—endocrine gland—alcohol dependence	0.00099	0.00794	CbGeAlD
Sirolimus—SLCO1B1—endocrine gland—alcohol dependence	0.000978	0.00784	CbGeAlD
Sirolimus—SLC47A1—testis—alcohol dependence	0.000945	0.00758	CbGeAlD
Sirolimus—SLC47A1—nervous system—alcohol dependence	0.000927	0.00744	CbGeAlD
Sirolimus—MTOR—brain—alcohol dependence	0.000917	0.00735	CbGeAlD
Sirolimus—SLC47A1—liver—alcohol dependence	0.000893	0.00716	CbGeAlD
Sirolimus—SLC47A1—central nervous system—alcohol dependence	0.000893	0.00716	CbGeAlD
Sirolimus—SLCO1B1—liver—alcohol dependence	0.000882	0.00707	CbGeAlD
Sirolimus—SLC47A1—cerebellum—alcohol dependence	0.000872	0.007	CbGeAlD
Sirolimus—FKBP1A—brain—alcohol dependence	0.000825	0.00661	CbGeAlD
Sirolimus—CYP3A5—pancreas—alcohol dependence	0.000711	0.0057	CbGeAlD
Sirolimus—SLC47A1—brain—alcohol dependence	0.000709	0.00568	CbGeAlD
Sirolimus—Visual impairment—Acamprosate—alcohol dependence	0.000624	0.00208	CcSEcCtD
Sirolimus—Dizziness—Disulfiram—alcohol dependence	0.000618	0.00205	CcSEcCtD
Sirolimus—Injury—Citalopram—alcohol dependence	0.00061	0.00203	CcSEcCtD
Sirolimus—Hallucination—Naltrexone—alcohol dependence	0.00061	0.00203	CcSEcCtD
Sirolimus—Pharyngitis—Naltrexone—alcohol dependence	0.000608	0.00202	CcSEcCtD
Sirolimus—CYP3A5—digestive system—alcohol dependence	0.000607	0.00487	CbGeAlD
Sirolimus—Tinnitus—Acamprosate—alcohol dependence	0.000604	0.00201	CcSEcCtD
Sirolimus—Connective tissue disorder—Naltrexone—alcohol dependence	0.000602	0.002	CcSEcCtD
Sirolimus—Increased appetite—Citalopram—alcohol dependence	0.000597	0.00199	CcSEcCtD
Sirolimus—Atrial fibrillation—Citalopram—alcohol dependence	0.000592	0.00197	CcSEcCtD
Sirolimus—Rash—Disulfiram—alcohol dependence	0.000589	0.00196	CcSEcCtD
Sirolimus—Headache—Disulfiram—alcohol dependence	0.000585	0.00195	CcSEcCtD
Sirolimus—Immune system disorder—Acamprosate—alcohol dependence	0.000585	0.00195	CcSEcCtD
Sirolimus—Chills—Acamprosate—alcohol dependence	0.000581	0.00193	CcSEcCtD
Sirolimus—CYP3A5—blood—alcohol dependence	0.000579	0.00464	CbGeAlD
Sirolimus—Hypoglycaemia—Citalopram—alcohol dependence	0.000575	0.00191	CcSEcCtD
Sirolimus—Tinnitus—Naltrexone—alcohol dependence	0.000571	0.0019	CcSEcCtD
Sirolimus—Cardiac disorder—Naltrexone—alcohol dependence	0.000569	0.00189	CcSEcCtD
Sirolimus—Malnutrition—Acamprosate—alcohol dependence	0.000564	0.00188	CcSEcCtD
Sirolimus—Hyponatraemia—Citalopram—alcohol dependence	0.000563	0.00187	CcSEcCtD
Sirolimus—Osteoarthritis—Citalopram—alcohol dependence	0.000561	0.00187	CcSEcCtD
Sirolimus—Angiopathy—Naltrexone—alcohol dependence	0.000556	0.00185	CcSEcCtD
Sirolimus—Flatulence—Acamprosate—alcohol dependence	0.000555	0.00185	CcSEcCtD
Sirolimus—Immune system disorder—Naltrexone—alcohol dependence	0.000553	0.00184	CcSEcCtD
Sirolimus—Tension—Acamprosate—alcohol dependence	0.000553	0.00184	CcSEcCtD
Sirolimus—Affect lability—Citalopram—alcohol dependence	0.000552	0.00184	CcSEcCtD
Sirolimus—Mediastinal disorder—Naltrexone—alcohol dependence	0.000552	0.00184	CcSEcCtD
Sirolimus—Chills—Naltrexone—alcohol dependence	0.00055	0.00183	CcSEcCtD
Sirolimus—Nervousness—Acamprosate—alcohol dependence	0.000547	0.00182	CcSEcCtD
Sirolimus—Back pain—Acamprosate—alcohol dependence	0.000545	0.00181	CcSEcCtD
Sirolimus—Muscle spasms—Acamprosate—alcohol dependence	0.000542	0.0018	CcSEcCtD
Sirolimus—Face oedema—Citalopram—alcohol dependence	0.000542	0.0018	CcSEcCtD
Sirolimus—Urinary retention—Citalopram—alcohol dependence	0.000534	0.00178	CcSEcCtD
Sirolimus—Malnutrition—Naltrexone—alcohol dependence	0.000533	0.00177	CcSEcCtD
Sirolimus—Mood swings—Citalopram—alcohol dependence	0.000532	0.00177	CcSEcCtD
Sirolimus—Tremor—Acamprosate—alcohol dependence	0.000528	0.00176	CcSEcCtD
Sirolimus—Flatulence—Naltrexone—alcohol dependence	0.000526	0.00175	CcSEcCtD
Sirolimus—Tension—Naltrexone—alcohol dependence	0.000523	0.00174	CcSEcCtD
Sirolimus—Ill-defined disorder—Acamprosate—alcohol dependence	0.000523	0.00174	CcSEcCtD
Sirolimus—Dehydration—Citalopram—alcohol dependence	0.000522	0.00174	CcSEcCtD
Sirolimus—Anaemia—Acamprosate—alcohol dependence	0.000521	0.00173	CcSEcCtD
Sirolimus—Liver function test abnormal—Citalopram—alcohol dependence	0.000518	0.00172	CcSEcCtD
Sirolimus—Agitation—Acamprosate—alcohol dependence	0.000518	0.00172	CcSEcCtD
Sirolimus—Nervousness—Naltrexone—alcohol dependence	0.000518	0.00172	CcSEcCtD
Sirolimus—Back pain—Naltrexone—alcohol dependence	0.000516	0.00172	CcSEcCtD
Sirolimus—Angioedema—Acamprosate—alcohol dependence	0.000515	0.00171	CcSEcCtD
Sirolimus—Muscle spasms—Naltrexone—alcohol dependence	0.000513	0.00171	CcSEcCtD
Sirolimus—Orthostatic hypotension—Citalopram—alcohol dependence	0.000512	0.00171	CcSEcCtD
Sirolimus—Hypokalaemia—Citalopram—alcohol dependence	0.000511	0.0017	CcSEcCtD
Sirolimus—Malaise—Acamprosate—alcohol dependence	0.000508	0.00169	CcSEcCtD
Sirolimus—Breast disorder—Citalopram—alcohol dependence	0.000507	0.00169	CcSEcCtD
Sirolimus—Syncope—Acamprosate—alcohol dependence	0.000506	0.00168	CcSEcCtD
Sirolimus—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000505	0.00168	CcSEcCtD
Sirolimus—Leukopenia—Acamprosate—alcohol dependence	0.000505	0.00168	CcSEcCtD
Sirolimus—CYP3A5—endocrine gland—alcohol dependence	0.000502	0.00403	CbGeAlD
Sirolimus—Tremor—Naltrexone—alcohol dependence	0.0005	0.00166	CcSEcCtD
Sirolimus—Palpitations—Acamprosate—alcohol dependence	0.000498	0.00166	CcSEcCtD
Sirolimus—Gastritis—Citalopram—alcohol dependence	0.000497	0.00165	CcSEcCtD
Sirolimus—Loss of consciousness—Acamprosate—alcohol dependence	0.000495	0.00165	CcSEcCtD
Sirolimus—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000495	0.00165	CcSEcCtD
Sirolimus—Ill-defined disorder—Naltrexone—alcohol dependence	0.000495	0.00165	CcSEcCtD
Sirolimus—Cough—Acamprosate—alcohol dependence	0.000492	0.00164	CcSEcCtD
Sirolimus—Agitation—Naltrexone—alcohol dependence	0.00049	0.00163	CcSEcCtD
Sirolimus—Abdominal distension—Citalopram—alcohol dependence	0.000488	0.00162	CcSEcCtD
Sirolimus—Angioedema—Naltrexone—alcohol dependence	0.000487	0.00162	CcSEcCtD
Sirolimus—Hypertension—Acamprosate—alcohol dependence	0.000487	0.00162	CcSEcCtD
Sirolimus—Asthma—Citalopram—alcohol dependence	0.000485	0.00161	CcSEcCtD
Sirolimus—Influenza—Citalopram—alcohol dependence	0.000485	0.00161	CcSEcCtD
Sirolimus—Dysphagia—Citalopram—alcohol dependence	0.000485	0.00161	CcSEcCtD
Sirolimus—Malaise—Naltrexone—alcohol dependence	0.000481	0.0016	CcSEcCtD
Sirolimus—Arthralgia—Acamprosate—alcohol dependence	0.00048	0.0016	CcSEcCtD
Sirolimus—Chest pain—Acamprosate—alcohol dependence	0.00048	0.0016	CcSEcCtD
Sirolimus—Myalgia—Acamprosate—alcohol dependence	0.00048	0.0016	CcSEcCtD
Sirolimus—Syncope—Naltrexone—alcohol dependence	0.000478	0.00159	CcSEcCtD
Sirolimus—Anxiety—Acamprosate—alcohol dependence	0.000478	0.00159	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000477	0.00159	CcSEcCtD
Sirolimus—Pancreatitis—Citalopram—alcohol dependence	0.000475	0.00158	CcSEcCtD
Sirolimus—Discomfort—Acamprosate—alcohol dependence	0.000474	0.00158	CcSEcCtD
Sirolimus—Palpitations—Naltrexone—alcohol dependence	0.000471	0.00157	CcSEcCtD
Sirolimus—Loss of consciousness—Naltrexone—alcohol dependence	0.000469	0.00156	CcSEcCtD
Sirolimus—Bronchitis—Citalopram—alcohol dependence	0.000466	0.00155	CcSEcCtD
Sirolimus—Cough—Naltrexone—alcohol dependence	0.000465	0.00155	CcSEcCtD
Sirolimus—Confusional state—Acamprosate—alcohol dependence	0.000464	0.00154	CcSEcCtD
Sirolimus—Pancytopenia—Citalopram—alcohol dependence	0.000461	0.00153	CcSEcCtD
Sirolimus—Hypertension—Naltrexone—alcohol dependence	0.00046	0.00153	CcSEcCtD
Sirolimus—Anaphylactic shock—Acamprosate—alcohol dependence	0.00046	0.00153	CcSEcCtD
Sirolimus—ABCB1—forebrain—alcohol dependence	0.00046	0.00369	CbGeAlD
Sirolimus—Infection—Acamprosate—alcohol dependence	0.000457	0.00152	CcSEcCtD
Sirolimus—CYP3A4—digestive system—alcohol dependence	0.000456	0.00366	CbGeAlD
Sirolimus—Myalgia—Naltrexone—alcohol dependence	0.000454	0.00151	CcSEcCtD
Sirolimus—Arthralgia—Naltrexone—alcohol dependence	0.000454	0.00151	CcSEcCtD
Sirolimus—Chest pain—Naltrexone—alcohol dependence	0.000454	0.00151	CcSEcCtD
Sirolimus—Dysuria—Citalopram—alcohol dependence	0.000453	0.00151	CcSEcCtD
Sirolimus—Shock—Acamprosate—alcohol dependence	0.000453	0.00151	CcSEcCtD
Sirolimus—Anxiety—Naltrexone—alcohol dependence	0.000452	0.00151	CcSEcCtD
Sirolimus—CYP3A5—liver—alcohol dependence	0.000452	0.00363	CbGeAlD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000451	0.0015	CcSEcCtD
Sirolimus—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000451	0.0015	CcSEcCtD
Sirolimus—Thrombocytopenia—Acamprosate—alcohol dependence	0.00045	0.0015	CcSEcCtD
Sirolimus—Tachycardia—Acamprosate—alcohol dependence	0.000449	0.00149	CcSEcCtD
Sirolimus—Discomfort—Naltrexone—alcohol dependence	0.000449	0.00149	CcSEcCtD
Sirolimus—Pollakiuria—Citalopram—alcohol dependence	0.000448	0.00149	CcSEcCtD
Sirolimus—Skin disorder—Acamprosate—alcohol dependence	0.000447	0.00149	CcSEcCtD
Sirolimus—Erectile dysfunction—Citalopram—alcohol dependence	0.000447	0.00149	CcSEcCtD
Sirolimus—Hyperhidrosis—Acamprosate—alcohol dependence	0.000445	0.00148	CcSEcCtD
Sirolimus—Weight increased—Citalopram—alcohol dependence	0.000441	0.00147	CcSEcCtD
Sirolimus—Confusional state—Naltrexone—alcohol dependence	0.000439	0.00146	CcSEcCtD
Sirolimus—Weight decreased—Citalopram—alcohol dependence	0.000439	0.00146	CcSEcCtD
Sirolimus—Anorexia—Acamprosate—alcohol dependence	0.000439	0.00146	CcSEcCtD
Sirolimus—Hyperglycaemia—Citalopram—alcohol dependence	0.000437	0.00146	CcSEcCtD
Sirolimus—Anaphylactic shock—Naltrexone—alcohol dependence	0.000435	0.00145	CcSEcCtD
Sirolimus—Oedema—Naltrexone—alcohol dependence	0.000435	0.00145	CcSEcCtD
Sirolimus—Pneumonia—Citalopram—alcohol dependence	0.000435	0.00145	CcSEcCtD
Sirolimus—CYP3A4—blood—alcohol dependence	0.000434	0.00348	CbGeAlD
Sirolimus—Infection—Naltrexone—alcohol dependence	0.000432	0.00144	CcSEcCtD
Sirolimus—Infestation NOS—Citalopram—alcohol dependence	0.000432	0.00144	CcSEcCtD
Sirolimus—Infestation—Citalopram—alcohol dependence	0.000432	0.00144	CcSEcCtD
Sirolimus—Hypotension—Acamprosate—alcohol dependence	0.00043	0.00143	CcSEcCtD
Sirolimus—Shock—Naltrexone—alcohol dependence	0.000428	0.00142	CcSEcCtD
Sirolimus—Nervous system disorder—Naltrexone—alcohol dependence	0.000427	0.00142	CcSEcCtD
Sirolimus—ABCB1—adrenal cortex—alcohol dependence	0.000426	0.00342	CbGeAlD
Sirolimus—Tachycardia—Naltrexone—alcohol dependence	0.000425	0.00141	CcSEcCtD
Sirolimus—Neuropathy peripheral—Citalopram—alcohol dependence	0.000424	0.00141	CcSEcCtD
Sirolimus—Skin disorder—Naltrexone—alcohol dependence	0.000423	0.00141	CcSEcCtD
Sirolimus—Stomatitis—Citalopram—alcohol dependence	0.000421	0.0014	CcSEcCtD
Sirolimus—Hyperhidrosis—Naltrexone—alcohol dependence	0.000421	0.0014	CcSEcCtD
Sirolimus—Conjunctivitis—Citalopram—alcohol dependence	0.00042	0.0014	CcSEcCtD
Sirolimus—Urinary tract infection—Citalopram—alcohol dependence	0.00042	0.0014	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000419	0.00139	CcSEcCtD
Sirolimus—Insomnia—Acamprosate—alcohol dependence	0.000416	0.00138	CcSEcCtD
Sirolimus—Anorexia—Naltrexone—alcohol dependence	0.000415	0.00138	CcSEcCtD
Sirolimus—Sweating—Citalopram—alcohol dependence	0.000415	0.00138	CcSEcCtD
Sirolimus—Paraesthesia—Acamprosate—alcohol dependence	0.000413	0.00137	CcSEcCtD
Sirolimus—Haematuria—Citalopram—alcohol dependence	0.000412	0.00137	CcSEcCtD
Sirolimus—Dyspnoea—Acamprosate—alcohol dependence	0.00041	0.00136	CcSEcCtD
Sirolimus—Somnolence—Acamprosate—alcohol dependence	0.000409	0.00136	CcSEcCtD
Sirolimus—Hepatobiliary disease—Citalopram—alcohol dependence	0.000409	0.00136	CcSEcCtD
Sirolimus—Epistaxis—Citalopram—alcohol dependence	0.000408	0.00136	CcSEcCtD
Sirolimus—Sinusitis—Citalopram—alcohol dependence	0.000406	0.00135	CcSEcCtD
Sirolimus—Dyspepsia—Acamprosate—alcohol dependence	0.000405	0.00135	CcSEcCtD
Sirolimus—Decreased appetite—Acamprosate—alcohol dependence	0.0004	0.00133	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000397	0.00132	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000397	0.00132	CcSEcCtD
Sirolimus—Insomnia—Naltrexone—alcohol dependence	0.000394	0.00131	CcSEcCtD
Sirolimus—Pain—Acamprosate—alcohol dependence	0.000393	0.00131	CcSEcCtD
Sirolimus—Constipation—Acamprosate—alcohol dependence	0.000393	0.00131	CcSEcCtD
Sirolimus—Paraesthesia—Naltrexone—alcohol dependence	0.000391	0.0013	CcSEcCtD
Sirolimus—Haemoglobin—Citalopram—alcohol dependence	0.00039	0.0013	CcSEcCtD
Sirolimus—Rhinitis—Citalopram—alcohol dependence	0.000389	0.00129	CcSEcCtD
Sirolimus—ABCB1—cardiovascular system—alcohol dependence	0.000389	0.00312	CbGeAlD
Sirolimus—Haemorrhage—Citalopram—alcohol dependence	0.000388	0.00129	CcSEcCtD
Sirolimus—Dyspnoea—Naltrexone—alcohol dependence	0.000388	0.00129	CcSEcCtD
Sirolimus—Somnolence—Naltrexone—alcohol dependence	0.000387	0.00129	CcSEcCtD
Sirolimus—Hallucination—Citalopram—alcohol dependence	0.000386	0.00129	CcSEcCtD
Sirolimus—Hypoaesthesia—Citalopram—alcohol dependence	0.000386	0.00129	CcSEcCtD
Sirolimus—Pharyngitis—Citalopram—alcohol dependence	0.000385	0.00128	CcSEcCtD
Sirolimus—Urinary tract disorder—Citalopram—alcohol dependence	0.000383	0.00128	CcSEcCtD
Sirolimus—Oedema peripheral—Citalopram—alcohol dependence	0.000382	0.00127	CcSEcCtD
Sirolimus—Connective tissue disorder—Citalopram—alcohol dependence	0.000381	0.00127	CcSEcCtD
Sirolimus—Urethral disorder—Citalopram—alcohol dependence	0.000381	0.00127	CcSEcCtD
Sirolimus—Feeling abnormal—Acamprosate—alcohol dependence	0.000379	0.00126	CcSEcCtD
Sirolimus—Decreased appetite—Naltrexone—alcohol dependence	0.000378	0.00126	CcSEcCtD
Sirolimus—ABCB1—pancreas—alcohol dependence	0.000378	0.00303	CbGeAlD
Sirolimus—CYP3A4—endocrine gland—alcohol dependence	0.000377	0.00302	CbGeAlD
Sirolimus—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000376	0.00125	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000376	0.00125	CcSEcCtD
Sirolimus—Visual impairment—Citalopram—alcohol dependence	0.000374	0.00124	CcSEcCtD
Sirolimus—Constipation—Naltrexone—alcohol dependence	0.000372	0.00124	CcSEcCtD
Sirolimus—Pain—Naltrexone—alcohol dependence	0.000372	0.00124	CcSEcCtD
Sirolimus—Body temperature increased—Acamprosate—alcohol dependence	0.000364	0.00121	CcSEcCtD
Sirolimus—Abdominal pain—Acamprosate—alcohol dependence	0.000364	0.00121	CcSEcCtD
Sirolimus—Tinnitus—Citalopram—alcohol dependence	0.000362	0.0012	CcSEcCtD
Sirolimus—Cardiac disorder—Citalopram—alcohol dependence	0.00036	0.0012	CcSEcCtD
Sirolimus—Feeling abnormal—Naltrexone—alcohol dependence	0.000359	0.00119	CcSEcCtD
Sirolimus—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000356	0.00118	CcSEcCtD
Sirolimus—ABCB1—gonad—alcohol dependence	0.000353	0.00283	CbGeAlD
Sirolimus—CYP3A4—nervous system—alcohol dependence	0.000353	0.00283	CbGeAlD
Sirolimus—Angiopathy—Citalopram—alcohol dependence	0.000352	0.00117	CcSEcCtD
Sirolimus—Immune system disorder—Citalopram—alcohol dependence	0.000351	0.00117	CcSEcCtD
Sirolimus—Mediastinal disorder—Citalopram—alcohol dependence	0.00035	0.00116	CcSEcCtD
Sirolimus—Chills—Citalopram—alcohol dependence	0.000348	0.00116	CcSEcCtD
Sirolimus—Body temperature increased—Naltrexone—alcohol dependence	0.000344	0.00114	CcSEcCtD
Sirolimus—Abdominal pain—Naltrexone—alcohol dependence	0.000344	0.00114	CcSEcCtD
Sirolimus—CYP3A4—liver—alcohol dependence	0.00034	0.00272	CbGeAlD
Sirolimus—CYP3A4—central nervous system—alcohol dependence	0.000339	0.00272	CbGeAlD
Sirolimus—Hypersensitivity—Acamprosate—alcohol dependence	0.000339	0.00113	CcSEcCtD
Sirolimus—Malnutrition—Citalopram—alcohol dependence	0.000338	0.00112	CcSEcCtD
Sirolimus—Flatulence—Citalopram—alcohol dependence	0.000333	0.00111	CcSEcCtD
Sirolimus—Tension—Citalopram—alcohol dependence	0.000332	0.0011	CcSEcCtD
Sirolimus—Asthenia—Acamprosate—alcohol dependence	0.00033	0.0011	CcSEcCtD
Sirolimus—Nervousness—Citalopram—alcohol dependence	0.000328	0.00109	CcSEcCtD
Sirolimus—Back pain—Citalopram—alcohol dependence	0.000327	0.00109	CcSEcCtD
Sirolimus—Pruritus—Acamprosate—alcohol dependence	0.000325	0.00108	CcSEcCtD
Sirolimus—Muscle spasms—Citalopram—alcohol dependence	0.000325	0.00108	CcSEcCtD
Sirolimus—ABCB1—digestive system—alcohol dependence	0.000323	0.00259	CbGeAlD
Sirolimus—Hypersensitivity—Naltrexone—alcohol dependence	0.000321	0.00107	CcSEcCtD
Sirolimus—Tremor—Citalopram—alcohol dependence	0.000317	0.00105	CcSEcCtD
Sirolimus—MTOR—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000315	0.00341	CbGpPWpGaD
Sirolimus—Diarrhoea—Acamprosate—alcohol dependence	0.000315	0.00105	CcSEcCtD
Sirolimus—Ill-defined disorder—Citalopram—alcohol dependence	0.000314	0.00104	CcSEcCtD
Sirolimus—MTOR—BDNF signaling pathway—CNR1—alcohol dependence	0.000313	0.00338	CbGpPWpGaD
Sirolimus—Anaemia—Citalopram—alcohol dependence	0.000312	0.00104	CcSEcCtD
Sirolimus—Asthenia—Naltrexone—alcohol dependence	0.000312	0.00104	CcSEcCtD
Sirolimus—Agitation—Citalopram—alcohol dependence	0.000311	0.00103	CcSEcCtD
Sirolimus—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.00031	0.00335	CbGpPWpGaD
Sirolimus—Angioedema—Citalopram—alcohol dependence	0.000309	0.00103	CcSEcCtD
Sirolimus—Pruritus—Naltrexone—alcohol dependence	0.000308	0.00102	CcSEcCtD
Sirolimus—ABCB1—blood—alcohol dependence	0.000307	0.00247	CbGeAlD
Sirolimus—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.000306	0.00331	CbGpPWpGaD
Sirolimus—Malaise—Citalopram—alcohol dependence	0.000305	0.00101	CcSEcCtD
Sirolimus—Dizziness—Acamprosate—alcohol dependence	0.000304	0.00101	CcSEcCtD
Sirolimus—ABCB1—midbrain—alcohol dependence	0.000304	0.00243	CbGeAlD
Sirolimus—Syncope—Citalopram—alcohol dependence	0.000303	0.00101	CcSEcCtD
Sirolimus—Leukopenia—Citalopram—alcohol dependence	0.000302	0.00101	CcSEcCtD
Sirolimus—Palpitations—Citalopram—alcohol dependence	0.000299	0.000994	CcSEcCtD
Sirolimus—MTOR—IFN-gamma pathway—EP300—alcohol dependence	0.000298	0.00322	CbGpPWpGaD
Sirolimus—Diarrhoea—Naltrexone—alcohol dependence	0.000298	0.000991	CcSEcCtD
Sirolimus—Loss of consciousness—Citalopram—alcohol dependence	0.000297	0.000988	CcSEcCtD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000297	0.00321	CbGpPWpGaD
Sirolimus—Cough—Citalopram—alcohol dependence	0.000295	0.000981	CcSEcCtD
Sirolimus—Vomiting—Acamprosate—alcohol dependence	0.000293	0.000973	CcSEcCtD
Sirolimus—Hypertension—Citalopram—alcohol dependence	0.000292	0.000971	CcSEcCtD
Sirolimus—Rash—Acamprosate—alcohol dependence	0.00029	0.000965	CcSEcCtD
Sirolimus—Dermatitis—Acamprosate—alcohol dependence	0.00029	0.000964	CcSEcCtD
Sirolimus—Headache—Acamprosate—alcohol dependence	0.000288	0.000959	CcSEcCtD
Sirolimus—Dizziness—Naltrexone—alcohol dependence	0.000288	0.000958	CcSEcCtD
Sirolimus—Chest pain—Citalopram—alcohol dependence	0.000288	0.000957	CcSEcCtD
Sirolimus—Arthralgia—Citalopram—alcohol dependence	0.000288	0.000957	CcSEcCtD
Sirolimus—Myalgia—Citalopram—alcohol dependence	0.000288	0.000957	CcSEcCtD
Sirolimus—Anxiety—Citalopram—alcohol dependence	0.000287	0.000954	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000286	0.000951	CcSEcCtD
Sirolimus—Discomfort—Citalopram—alcohol dependence	0.000284	0.000946	CcSEcCtD
Sirolimus—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.00028	0.00303	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00028	0.00302	CbGpPWpGaD
Sirolimus—Confusional state—Citalopram—alcohol dependence	0.000278	0.000925	CcSEcCtD
Sirolimus—Vomiting—Naltrexone—alcohol dependence	0.000277	0.000921	CcSEcCtD
Sirolimus—Anaphylactic shock—Citalopram—alcohol dependence	0.000276	0.000918	CcSEcCtD
Sirolimus—Oedema—Citalopram—alcohol dependence	0.000276	0.000918	CcSEcCtD
Sirolimus—Rash—Naltrexone—alcohol dependence	0.000274	0.000913	CcSEcCtD
Sirolimus—Dermatitis—Naltrexone—alcohol dependence	0.000274	0.000912	CcSEcCtD
Sirolimus—Infection—Citalopram—alcohol dependence	0.000274	0.000912	CcSEcCtD
Sirolimus—Nausea—Acamprosate—alcohol dependence	0.000273	0.000909	CcSEcCtD
Sirolimus—CYP3A7—Biological oxidations—ALDH2—alcohol dependence	0.000273	0.00295	CbGpPWpGaD
Sirolimus—Headache—Naltrexone—alcohol dependence	0.000273	0.000907	CcSEcCtD
Sirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000271	0.00294	CbGpPWpGaD
Sirolimus—Shock—Citalopram—alcohol dependence	0.000271	0.000903	CcSEcCtD
Sirolimus—Nervous system disorder—Citalopram—alcohol dependence	0.00027	0.0009	CcSEcCtD
Sirolimus—Thrombocytopenia—Citalopram—alcohol dependence	0.00027	0.000898	CcSEcCtD
Sirolimus—Tachycardia—Citalopram—alcohol dependence	0.000269	0.000896	CcSEcCtD
Sirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000268	0.0029	CbGpPWpGaD
Sirolimus—Skin disorder—Citalopram—alcohol dependence	0.000268	0.000891	CcSEcCtD
Sirolimus—Hyperhidrosis—Citalopram—alcohol dependence	0.000267	0.000887	CcSEcCtD
Sirolimus—ABCB1—endocrine gland—alcohol dependence	0.000267	0.00214	CbGeAlD
Sirolimus—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000263	0.00285	CbGpPWpGaD
Sirolimus—Anorexia—Citalopram—alcohol dependence	0.000263	0.000875	CcSEcCtD
Sirolimus—Nausea—Naltrexone—alcohol dependence	0.000259	0.00086	CcSEcCtD
Sirolimus—Hypotension—Citalopram—alcohol dependence	0.000258	0.000857	CcSEcCtD
Sirolimus—ABCB1—testis—alcohol dependence	0.000254	0.00204	CbGeAlD
Sirolimus—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000251	0.000836	CcSEcCtD
Sirolimus—ABCB1—nervous system—alcohol dependence	0.00025	0.002	CbGeAlD
Sirolimus—Insomnia—Citalopram—alcohol dependence	0.000249	0.00083	CcSEcCtD
Sirolimus—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000248	0.00268	CbGpPWpGaD
Sirolimus—Paraesthesia—Citalopram—alcohol dependence	0.000248	0.000824	CcSEcCtD
Sirolimus—Dyspnoea—Citalopram—alcohol dependence	0.000246	0.000818	CcSEcCtD
Sirolimus—EIF4E—Signaling Pathways—OPRK1—alcohol dependence	0.000245	0.00266	CbGpPWpGaD
Sirolimus—Somnolence—Citalopram—alcohol dependence	0.000245	0.000816	CcSEcCtD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000245	0.00265	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000244	0.00264	CbGpPWpGaD
Sirolimus—Dyspepsia—Citalopram—alcohol dependence	0.000243	0.000808	CcSEcCtD
Sirolimus—ABCB1—liver—alcohol dependence	0.00024	0.00193	CbGeAlD
Sirolimus—ABCB1—central nervous system—alcohol dependence	0.00024	0.00193	CbGeAlD
Sirolimus—Decreased appetite—Citalopram—alcohol dependence	0.00024	0.000798	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000238	0.000792	CcSEcCtD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000236	0.00256	CbGpPWpGaD
Sirolimus—Constipation—Citalopram—alcohol dependence	0.000236	0.000785	CcSEcCtD
Sirolimus—Pain—Citalopram—alcohol dependence	0.000236	0.000785	CcSEcCtD
Sirolimus—ABCB1—cerebellum—alcohol dependence	0.000235	0.00188	CbGeAlD
Sirolimus—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000232	0.00251	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—WASF2—alcohol dependence	0.000227	0.00246	CbGpPWpGaD
Sirolimus—Feeling abnormal—Citalopram—alcohol dependence	0.000227	0.000756	CcSEcCtD
Sirolimus—Gastrointestinal pain—Citalopram—alcohol dependence	0.000226	0.00075	CcSEcCtD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00022	0.00238	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—CYP2E1—alcohol dependence	0.000218	0.00236	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—WASF1—alcohol dependence	0.000218	0.00236	CbGpPWpGaD
Sirolimus—Abdominal pain—Citalopram—alcohol dependence	0.000218	0.000725	CcSEcCtD
Sirolimus—Body temperature increased—Citalopram—alcohol dependence	0.000218	0.000725	CcSEcCtD
Sirolimus—FGF2—Innate Immune System—WASF2—alcohol dependence	0.000217	0.00235	CbGpPWpGaD
Sirolimus—CYP3A7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000215	0.00233	CbGpPWpGaD
Sirolimus—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000211	0.00228	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—WASF1—alcohol dependence	0.000208	0.00225	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000205	0.00222	CbGpPWpGaD
Sirolimus—Hypersensitivity—Citalopram—alcohol dependence	0.000203	0.000676	CcSEcCtD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000203	0.0022	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—GGT1—alcohol dependence	0.0002	0.00217	CbGpPWpGaD
Sirolimus—Asthenia—Citalopram—alcohol dependence	0.000198	0.000658	CcSEcCtD
Sirolimus—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000197	0.00213	CbGpPWpGaD
Sirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000196	0.00212	CbGpPWpGaD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000196	0.00212	CbGpPWpGaD
Sirolimus—Pruritus—Citalopram—alcohol dependence	0.000195	0.000649	CcSEcCtD
Sirolimus—ABCB1—brain—alcohol dependence	0.000191	0.00153	CbGeAlD
Sirolimus—Diarrhoea—Citalopram—alcohol dependence	0.000189	0.000628	CcSEcCtD
Sirolimus—Dizziness—Citalopram—alcohol dependence	0.000182	0.000607	CcSEcCtD
Sirolimus—FKBP1A—Signaling Pathways—OPRK1—alcohol dependence	0.00018	0.00195	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—MAOA—alcohol dependence	0.00018	0.00194	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000176	0.0019	CbGpPWpGaD
Sirolimus—Vomiting—Citalopram—alcohol dependence	0.000175	0.000583	CcSEcCtD
Sirolimus—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000175	0.00189	CbGpPWpGaD
Sirolimus—Rash—Citalopram—alcohol dependence	0.000174	0.000579	CcSEcCtD
Sirolimus—Dermatitis—Citalopram—alcohol dependence	0.000174	0.000578	CcSEcCtD
Sirolimus—Headache—Citalopram—alcohol dependence	0.000173	0.000575	CcSEcCtD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000173	0.00187	CbGpPWpGaD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00017	0.00184	CbGpPWpGaD
Sirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000168	0.00182	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000166	0.0018	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—OPRD1—alcohol dependence	0.000165	0.00178	CbGpPWpGaD
Sirolimus—Nausea—Citalopram—alcohol dependence	0.000164	0.000545	CcSEcCtD
Sirolimus—MTOR—Innate Immune System—WASF2—alcohol dependence	0.000161	0.00174	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000161	0.00174	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000159	0.00172	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—GRIN2B—alcohol dependence	0.000158	0.00171	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PDYN—alcohol dependence	0.000158	0.00171	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000158	0.00171	CbGpPWpGaD
Sirolimus—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000156	0.00168	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—WASF1—alcohol dependence	0.000154	0.00167	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000149	0.00162	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000148	0.00161	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CRHR1—alcohol dependence	0.000147	0.00159	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—WASF2—alcohol dependence	0.000147	0.00159	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—GGT1—alcohol dependence	0.000145	0.00157	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000142	0.00154	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—WASF1—alcohol dependence	0.000141	0.00153	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CHRM2—alcohol dependence	0.000138	0.0015	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000138	0.00149	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000138	0.00149	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADH6—alcohol dependence	0.000137	0.00149	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—OPRK1—alcohol dependence	0.000136	0.00148	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.00013	0.00141	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—MAOA—alcohol dependence	0.00013	0.0014	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—OPRM1—alcohol dependence	0.000127	0.00137	CbGpPWpGaD
Sirolimus—FGF2—Immune System—WASF2—alcohol dependence	0.000126	0.00137	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADH6—alcohol dependence	0.000126	0.00136	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000122	0.00132	CbGpPWpGaD
Sirolimus—FGF2—Immune System—WASF1—alcohol dependence	0.000121	0.00131	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—OPRD1—alcohol dependence	0.000121	0.00131	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—POMC—alcohol dependence	0.000119	0.00129	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—POMC—alcohol dependence	0.000117	0.00126	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NPY—alcohol dependence	0.000117	0.00126	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PDYN—alcohol dependence	0.000116	0.00126	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADH1A—alcohol dependence	0.000114	0.00123	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000114	0.00123	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR1B—alcohol dependence	0.000113	0.00122	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CRH—alcohol dependence	0.000113	0.00122	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000109	0.00118	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000108	0.00117	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—WASF2—alcohol dependence	0.000108	0.00117	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CRHR1—alcohol dependence	0.000108	0.00117	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—GOT2—alcohol dependence	0.000107	0.00115	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADH1A—alcohol dependence	0.000105	0.00113	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—WASF1—alcohol dependence	0.000103	0.00112	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CHRM2—alcohol dependence	0.000101	0.0011	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—OPRK1—alcohol dependence	0.000101	0.0011	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—DRD4—alcohol dependence	9.85e-05	0.00107	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADH4—alcohol dependence	9.68e-05	0.00105	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CNR1—alcohol dependence	9.41e-05	0.00102	CbGpPWpGaD
Sirolimus—MTOR—Immune System—WASF2—alcohol dependence	9.38e-05	0.00101	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—OPRM1—alcohol dependence	9.31e-05	0.00101	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—GOT1—alcohol dependence	9.22e-05	0.000997	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR7—alcohol dependence	9.18e-05	0.000993	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—DRD2—alcohol dependence	9.18e-05	0.000993	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	9.17e-05	0.000992	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—OPRD1—alcohol dependence	9.17e-05	0.000992	CbGpPWpGaD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	9.12e-05	0.000987	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADH6—alcohol dependence	9.12e-05	0.000986	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	9.1e-05	0.000984	CbGpPWpGaD
Sirolimus—MTOR—Immune System—WASF1—alcohol dependence	9e-05	0.000973	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADH4—alcohol dependence	8.89e-05	0.000961	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	8.8e-05	0.000952	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PDYN—alcohol dependence	8.79e-05	0.000951	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NPY—alcohol dependence	8.57e-05	0.000927	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	8.46e-05	0.000915	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—POMC—alcohol dependence	8.45e-05	0.000914	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.38e-05	0.000907	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CRH—alcohol dependence	8.27e-05	0.000894	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR1B—alcohol dependence	8.27e-05	0.000894	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADH7—alcohol dependence	8.23e-05	0.000891	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—WASF2—alcohol dependence	8.17e-05	0.000884	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CRHR1—alcohol dependence	8.17e-05	0.000884	CbGpPWpGaD
Sirolimus—FGF2—Disease—GOT2—alcohol dependence	8.09e-05	0.000875	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GGT2—alcohol dependence	7.89e-05	0.000854	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—WASF1—alcohol dependence	7.84e-05	0.000848	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AVP—alcohol dependence	7.73e-05	0.000836	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CHRM2—alcohol dependence	7.69e-05	0.000831	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADH7—alcohol dependence	7.56e-05	0.000817	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADH1A—alcohol dependence	7.55e-05	0.000817	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	7.48e-05	0.000809	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.39e-05	0.0008	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	7.33e-05	0.000793	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GGT2—alcohol dependence	7.24e-05	0.000784	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	7.23e-05	0.000782	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—DRD4—alcohol dependence	7.23e-05	0.000782	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADH1B—alcohol dependence	7.22e-05	0.000781	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—OPRM1—alcohol dependence	7.06e-05	0.000763	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—AVP—alcohol dependence	7e-05	0.000757	CbGpPWpGaD
Sirolimus—FGF2—Disease—GOT1—alcohol dependence	6.98e-05	0.000756	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—EP300—alcohol dependence	6.97e-05	0.000754	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CNR1—alcohol dependence	6.9e-05	0.000746	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADH6—alcohol dependence	6.88e-05	0.000744	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—OPRD1—alcohol dependence	6.81e-05	0.000736	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—GGT1—alcohol dependence	6.73e-05	0.000728	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—DRD2—alcohol dependence	6.73e-05	0.000728	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR7—alcohol dependence	6.73e-05	0.000728	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADH1B—alcohol dependence	6.63e-05	0.000717	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PDYN—alcohol dependence	6.53e-05	0.000706	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NPY—alcohol dependence	6.49e-05	0.000702	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR2A—alcohol dependence	6.43e-05	0.000695	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADH4—alcohol dependence	6.42e-05	0.000695	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CRH—alcohol dependence	6.27e-05	0.000678	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR1B—alcohol dependence	6.27e-05	0.000678	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CRHR1—alcohol dependence	6.07e-05	0.000656	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—WASF2—alcohol dependence	6.07e-05	0.000656	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—MAOA—alcohol dependence	6.03e-05	0.000653	CbGpPWpGaD
Sirolimus—MTOR—Disease—GOT2—alcohol dependence	6e-05	0.00065	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MAOB—alcohol dependence	5.98e-05	0.000647	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—WASF1—alcohol dependence	5.82e-05	0.000629	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CHRM2—alcohol dependence	5.7e-05	0.000617	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADH1A—alcohol dependence	5.7e-05	0.000617	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—EP300—alcohol dependence	5.69e-05	0.000616	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AVP—alcohol dependence	5.67e-05	0.000613	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MAOB—alcohol dependence	5.49e-05	0.000594	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—DRD4—alcohol dependence	5.48e-05	0.000592	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADH7—alcohol dependence	5.46e-05	0.000591	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—EP300—alcohol dependence	5.27e-05	0.00057	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—OPRM1—alcohol dependence	5.24e-05	0.000566	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GGT2—alcohol dependence	5.24e-05	0.000566	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CNR1—alcohol dependence	5.23e-05	0.000566	CbGpPWpGaD
Sirolimus—MTOR—Disease—GOT1—alcohol dependence	5.18e-05	0.000561	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—POMC—alcohol dependence	5.13e-05	0.000555	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—DRD2—alcohol dependence	5.1e-05	0.000552	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR7—alcohol dependence	5.1e-05	0.000552	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALDH2—alcohol dependence	5.09e-05	0.00055	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—EP300—alcohol dependence	5.03e-05	0.000544	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.89e-05	0.000529	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADH4—alcohol dependence	4.85e-05	0.000524	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NPY—alcohol dependence	4.82e-05	0.000521	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADH1B—alcohol dependence	4.79e-05	0.000518	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR2A—alcohol dependence	4.71e-05	0.00051	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALDH2—alcohol dependence	4.67e-05	0.000505	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR1B—alcohol dependence	4.65e-05	0.000503	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CRH—alcohol dependence	4.65e-05	0.000503	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GOT2—alcohol dependence	4.32e-05	0.000468	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AVP—alcohol dependence	4.29e-05	0.000464	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADH6—alcohol dependence	4.24e-05	0.000458	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.24e-05	0.000458	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADH7—alcohol dependence	4.12e-05	0.000446	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CYP2E1—alcohol dependence	4.07e-05	0.00044	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—DRD4—alcohol dependence	4.06e-05	0.00044	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GOT2—alcohol dependence	3.97e-05	0.000429	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MAOB—alcohol dependence	3.97e-05	0.000429	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GGT2—alcohol dependence	3.95e-05	0.000427	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—POMC—alcohol dependence	3.93e-05	0.000425	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	3.89e-05	0.000421	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CNR1—alcohol dependence	3.88e-05	0.00042	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—DRD2—alcohol dependence	3.79e-05	0.00041	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR7—alcohol dependence	3.79e-05	0.00041	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—POMC—alcohol dependence	3.77e-05	0.000407	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GOT1—alcohol dependence	3.73e-05	0.000404	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GGT1—alcohol dependence	3.73e-05	0.000404	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CYP2E1—alcohol dependence	3.73e-05	0.000404	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—EP300—alcohol dependence	3.73e-05	0.000404	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADH1B—alcohol dependence	3.61e-05	0.000391	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR2A—alcohol dependence	3.57e-05	0.000387	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—EP300—alcohol dependence	3.57e-05	0.000386	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.51e-05	0.00038	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	3.5e-05	0.000379	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GGT1—alcohol dependence	3.43e-05	0.000371	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GOT1—alcohol dependence	3.43e-05	0.000371	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—EP300—alcohol dependence	3.41e-05	0.000368	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALDH2—alcohol dependence	3.37e-05	0.000365	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MAOA—alcohol dependence	3.35e-05	0.000362	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.24e-05	0.000351	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AVP—alcohol dependence	3.19e-05	0.000345	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MAOA—alcohol dependence	3.07e-05	0.000332	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MAOB—alcohol dependence	2.99e-05	0.000324	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADH4—alcohol dependence	2.99e-05	0.000323	CbGpPWpGaD
Sirolimus—FGF2—Immune System—EP300—alcohol dependence	2.93e-05	0.000317	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GOT2—alcohol dependence	2.87e-05	0.00031	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—POMC—alcohol dependence	2.85e-05	0.000309	CbGpPWpGaD
Sirolimus—FGF2—Disease—EP300—alcohol dependence	2.7e-05	0.000292	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CYP2E1—alcohol dependence	2.7e-05	0.000292	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR2A—alcohol dependence	2.65e-05	0.000287	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALDH2—alcohol dependence	2.55e-05	0.000275	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADH7—alcohol dependence	2.54e-05	0.000275	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—EP300—alcohol dependence	2.5e-05	0.00027	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GGT1—alcohol dependence	2.48e-05	0.000268	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GOT1—alcohol dependence	2.48e-05	0.000268	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GGT2—alcohol dependence	2.43e-05	0.000263	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.23e-05	0.000241	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MAOA—alcohol dependence	2.22e-05	0.00024	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—POMC—alcohol dependence	2.18e-05	0.000236	CbGpPWpGaD
Sirolimus—MTOR—Immune System—EP300—alcohol dependence	2.17e-05	0.000235	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GOT2—alcohol dependence	2.16e-05	0.000234	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—POMC—alcohol dependence	2.12e-05	0.000229	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.04e-05	0.00022	CbGpPWpGaD
Sirolimus—MTOR—Disease—EP300—alcohol dependence	2.01e-05	0.000217	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—POMC—alcohol dependence	2e-05	0.000216	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—EP300—alcohol dependence	1.89e-05	0.000205	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GOT1—alcohol dependence	1.87e-05	0.000202	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GGT1—alcohol dependence	1.87e-05	0.000202	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MAOB—alcohol dependence	1.84e-05	0.0002	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MAOA—alcohol dependence	1.67e-05	0.000181	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.57e-05	0.00017	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—POMC—alcohol dependence	1.44e-05	0.000156	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—EP300—alcohol dependence	1.44e-05	0.000156	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—EP300—alcohol dependence	1.4e-05	0.000152	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GOT2—alcohol dependence	1.33e-05	0.000144	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—EP300—alcohol dependence	1.33e-05	0.000143	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.25e-05	0.000136	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GGT1—alcohol dependence	1.15e-05	0.000125	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GOT1—alcohol dependence	1.15e-05	0.000125	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—POMC—alcohol dependence	1.09e-05	0.000118	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MAOA—alcohol dependence	1.03e-05	0.000112	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—EP300—alcohol dependence	9.59e-06	0.000104	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—EP300—alcohol dependence	7.23e-06	7.82e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—POMC—alcohol dependence	6.72e-06	7.27e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—EP300—alcohol dependence	4.46e-06	4.82e-05	CbGpPWpGaD
